Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were isolated and purified from oxLDL and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. PAz-PC is one of the predominant oxLDL species and may be one of the important structural determinants of oxLDL.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 約 35 days | ¥ 22,500 |
5 mg | 約 35 days | ¥ 105,500 |
10 mg | 約 35 days | ¥ 181,000 |
25 mg | 約 35 days | ¥ 402,000 |
説明 | Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were isolated and purified from oxLDL and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. PAz-PC is one of the predominant oxLDL species and may be one of the important structural determinants of oxLDL. |
分子量 | 665.84 |
分子式 | C33H64NO10P |
CAS No. | 117746-89-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PBS (pH 7.2): 5 mg/mL
DMF: 1 mg/mL
DMSO: 5 mg/mL
Ethanol: 30 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PAz-PC 117746-89-1 PAzPC PAz PC Inhibitor inhibitor inhibit